Vectiopep

Tartu, Estonia · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to develop cancer immunotherapies. Vectiopep is based in Tartu, Estonia and was founded in 2022. Its last reported valuation was $3 million in Apr 2024. It has raised $460,000.

Last reported valuation
$3.0M
Oct 2026
Priced at
—
Total raised
$460K
Last round
—

Who backs Vectiopep?

6 investors
InvestorType
Sofigama InvestmentsVenture capital
Dag Nurm—
Ivo Remmelg—
Missouri Innovation Center—
Tartu TaeduPark—
UniTartu Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vectiopep investors

6 investors are on record for Vectiopep, including Sofigama Investments, Dag Nurm, Ivo Remmelg and Missouri Innovation Center.

Free account
More of Vectiopep with a free account
  • ·Watch Vectiopep: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Vectiopep. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View